However, this trial was limited by small sample size and potential flaws in the selection of endpoints (NCT04916470 and NCT05371496) [52]
Dose schedule considerations by body weight The clinical trials used fixed doses (not weight-based dosing), which means a 200-pound person and a 300-pound person received the same milligram amount
Due to the high cost of the branded GLP-1 drugs, which can top more than $1k a month without insurance coverage, new options have emerged for consumers, including direct-to-consumer access to compounded versions of these medications
Current evidence suggests that dapagliflozin may elevate the risk of bladder and breast cancers, whereas other SGLT2 inhibitors have not demonstrated such associations [10]
This product is neither a drug, food, nor cosmetic, and must not be misrepresented, misused, or mislabeled as such